自磷酸化
p38丝裂原活化蛋白激酶
MAPK/ERK通路
蛋白激酶A
氧化应激
细胞生物学
激酶
生物
癌症研究
内科学
医学
内分泌学
作者
Jianru Shi,Jian Guan,Bingbing Jiang,Daniel Brenner,Federica del Monte,Jennifer E. Ward,Lawreen H. Connors,Douglas B. Sawyer,Marc J. Semigran,Thomas E. MacGillivray,David C. Seldin,Rodney H. Falk,Ronglih Liao
标识
DOI:10.1073/pnas.0912263107
摘要
Patients with primary (AL) cardiac amyloidosis suffer from progressive cardiomyopathy with a median survival of less than 8 months and a 5-year survival of <10%. Contributing to this poor prognosis is the fact that these patients generally do not tolerate standard heart failure therapies. The molecular mechanisms underlying this deadly form of heart disease remain unclear. Although interstitial amyloid fibril deposition of Ig light chain proteins is a major cause of cardiac dysfunction in AL cardiac amyloidosis, we have previously shown that amyloid precursor proteins directly impair cardiac function at the cellular and isolated organ levels, independent of fibril formation. In this study, we report that amyloidogenic light chain (AL-LC) proteins provoke oxidative stress, cellular dysfunction, and apoptosis in isolated adult cardiomyocytes through activation of p38 mitogen-activated protein kinase (MAPK). AL-LC–induced p38 activation was found to be independent of the upstream MAPK kinase, MKK3/6, and instead depends upon transforming growth factor-β-activated protein kinase-1 binding protein-1 (TAB1)-mediated p38α MAPK autophosphorylation. Treatment of cardiomyocytes with SB203580, a selective p38 MAPK inhibitor, significantly attenuated AL-LC–induced oxidative stress, cellular dysfunction, and apoptosis. Our data provide a unique mechanistic insight into the pathogenesis of AL-LC cardiac toxicity and suggest that TAB1-mediated p38α MAPK autophosphorylation may serve as an important event leading to cardiac dysfunction and subsequent heart failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI